FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways
Article in Pharmacological Research (December 2021)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
Article in Frontiers in Oncology (February 2021)
Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours
Article in Oncology Reports (January 2021)